Biotest Switzerland and the Swiss Society for Allergology and Immunology (SSAI) announce the Biotest Award 2022, on Understanding and making use of naturally occurring antibodies
The award of CHF 10’000.- is sponsored by Biotest Switzerland
Naturally occurring antibodies are often involved in autoimmune, inflammatory, and allergic disorders, infections, cancer and transplant rejections. Such antibodies can promote disease or can be beneficial for patients. Treatment with human plasma products is increasingly helpful, although the mechanisms are not always clear. This award will be given to a scientific basic or clinical study that improves the understanding of disease mechanisms involving naturally occurring antibodies and therapies with human plasma products.
Applicants are asked to provide a cover letter (max 1 page) and the manuscript of their work. All documents should be assembled to one single PDF file, fully searchable (i.e. generated electronically, not by scanning).
The award will be attributed to first and last author(s). They will be invited to present their study at the 25th Allergy Immunology Update Meeting taking place from 27 – 29 January 2023.
The application deadline is the 30 October 2022 for sending your application to Jolanda Trachsel, General Manager SSAI, by email to firstname.lastname@example.org.